胰高血糖素样肽-1受体激动剂与肥胖相关癌症：Vigibase®中的不成比例性分析 - Suppr

Suppr

超能文献

GLP 1 receptor agonists and obesity-associated cancers: a disproportionality analysis in Vigibase®.

作者信息

Montastruc Jean-Louis

机构信息

, Toulouse, France.

出版信息

Eur J Clin Pharmacol. 2024 Dec;80(12):1999-2001. doi: 10.1007/s00228-024-03761-y. Epub 2024 Sep 27.

DOI:10.1007/s00228-024-03761-y

PMID:39331139

Abstract

摘要

相似文献

GLP 1 receptor agonists and obesity-associated cancers: a disproportionality analysis in Vigibase®.

Eur J Clin Pharmacol. 2024 Dec;80(12):1999-2001. doi: 10.1007/s00228-024-03761-y. Epub 2024 Sep 27.

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase®).

J Affect Disord. 2025 Jan 15;369:922-927. doi: 10.1016/j.jad.2024.10.062. Epub 2024 Oct 19.

Impulse control disorders associated with dopaminergic drugs: A disproportionality analysis using vigibase.

Eur Neuropsychopharmacol. 2022 May;58:30-38. doi: 10.1016/j.euroneuro.2022.01.113. Epub 2022 Feb 19.

Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBase.

Pharmaceuticals (Basel). 2023 Oct 5;16(10):1420. doi: 10.3390/ph16101420.

Calcitonin gene-related peptide antagonists in pregnancy: a disproportionality analysis in VigiBase.

J Headache Pain. 2024 Jan 19;25(1):10. doi: 10.1186/s10194-024-01715-4.

Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database.

BMC Med. 2024 Feb 14;22(1):65. doi: 10.1186/s12916-024-03274-6.

Safety of Glucagon-Like Peptide-1 Receptor Agonists: A Real-World Study Based on the US FDA Adverse Event Reporting System Database.

Clin Drug Investig. 2022 Nov;42(11):965-975. doi: 10.1007/s40261-022-01202-1. Epub 2022 Sep 30.

Psychiatric adverse events associated with GLP-1 receptor agonists: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database.

Front Endocrinol (Lausanne). 2024 Feb 6;15:1330936. doi: 10.3389/fendo.2024.1330936. eCollection 2024.

The potential antidepressant effect of antidiabetic agents: New insights from a pharmacovigilance study based on data from the reporting system databases FAERS and VigiBase.

Front Pharmacol. 2023 Feb 17;14:1128387. doi: 10.3389/fphar.2023.1128387. eCollection 2023.

Drug-Induced Dental Caries: A Disproportionality Analysis Using Data from VigiBase.

Drug Saf. 2017 Dec;40(12):1249-1258. doi: 10.1007/s40264-017-0575-5.

本文引用的文献

Unveiling the Burden of Drug-Induced Impulsivity: A Network Analysis of the FDA Adverse Event Reporting System.

Drug Saf. 2024 Dec;47(12):1275-1292. doi: 10.1007/s40264-024-01471-z. Epub 2024 Aug 15.

Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes.

JAMA Netw Open. 2024 Jul 1;7(7):e2421305. doi: 10.1001/jamanetworkopen.2024.21305.

Case-non-case studies: Principle, methods, bias and interpretation.

Therapie. 2019 Apr;74(2):225-232. doi: 10.1016/j.therap.2019.01.006. Epub 2019 Jan 31.

What is pharmacoepidemiology? Definition, methods, interest and clinical applications.

Therapie. 2019 Apr;74(2):169-174. doi: 10.1016/j.therap.2018.08.001. Epub 2018 Oct 10.

Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database.

Br J Clin Pharmacol. 2011 Dec;72(6):905-8. doi: 10.1111/j.1365-2125.2011.04037.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验